β-Thromboglobulin and incident cardiovascular disease risk: The Atherosclerosis Risk in Communities study

In the prospective population-based ARIC cohort, β-thromboglobulin was not associated with CVD risk. Our results do not support the hypothesis that a blood marker of higher platelet activity reflects increased future risk of CVD in the general population.